Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 1 - 20
of 219
Sort by Relevance
|
Sort by Date
1 Jul 2024, 8:00 am
Merrell Dow Pharmaceuticals, Inc. [read post]
22 Jun 2024, 7:16 am
Merrell Dow Pharmaceuticals, it requires that expert testimony be both relevant and reliable. [read post]
22 Jun 2024, 7:16 am
Merrell Dow Pharmaceuticals, it requires that expert testimony be both relevant and reliable. [read post]
22 Jun 2024, 7:16 am
Merrell Dow Pharmaceuticals, it requires that expert testimony be both relevant and reliable. [read post]
28 Apr 2024, 6:31 pm
Merrell Dow Pharmaceuticals, Inc. (1993). [read post]
28 Feb 2024, 2:00 pm
Merrell Dow Pharms., Inc. (1993) 509 U.S. 579, 593 (Daubert); see also Primiano v. [read post]
27 Feb 2024, 12:07 pm
This would be a Scott v. [read post]
17 Dec 2023, 2:43 pm
Merrell Dow Pharmaceuticals, Inc., 113 S.Ct. 2786 (1993), held that the “Frye standard,” i.e., the long dominant legal standard that “expert” testimony must have “general acceptance” in the scientific community or other relevant areas of knowledge, was no longer the legal standard for admitting expert testimony in evidence. [read post]
19 Nov 2023, 2:31 pm
Merrell Dow Pharmaceuticals, Inc.,[2] The Supreme Court suggested that peer review of studies relied upon by a challenged expert witness should be a factor in determining the admissibility of that expert witness’s opinion. [read post]
12 Jun 2023, 1:09 pm
In Matrixx Initiatives, Inc. v. [read post]
16 Mar 2023, 4:30 am
Merrell Dow Pharmaceuticals, Inc., (1993), on the standards for expert testimony, with 24 departing states, United States v. [read post]
17 Jun 2022, 2:09 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), legal scholars, judges, and lawyers have struggled with the structure and validity of expert opinion on specific causation. [read post]
7 May 2022, 5:01 am
Merrell Dow Pharmaceuticals, Inc. [read post]
3 May 2022, 10:28 am
In Daubert v. [read post]
29 Jan 2022, 6:24 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993), Fed.Rules, Evid.Rules 104(a), 702. [read post]
5 Jan 2022, 4:33 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S.Ct. 2786, 125 L.Ed.2d 469 (1993).Where does the universe of disability terminate? [read post]
12 Dec 2021, 2:22 pm
Whitehall Labs., Inc., 874 F. [read post]
17 Jun 2021, 12:29 pm
As a result, so-called Daubert hearings began taking place in district courts around the country, in parallel with other centralized proceedings in MDL 926. [read post]
14 May 2021, 9:48 am
Merrell Dow Pharmaceuticals, Inc. [read post]
14 May 2021, 9:48 am
Merrell Dow Pharmaceuticals, Inc. [read post]
